ROS1, which encodes a receptor tyrosine kinase with no known ligands, is activated in ~1–2% of NSCLC by gene rearrangements resulting in novel chimeric fusion proteins, SLC34A2-ROS and CD74-ROS [42]. This evidence concerns the gene CD74 and non-small cell lung carcinoma.